Flexion Therapeutics Obtains $20,000,000 Series B Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01bc29a0-f5ce-4692-8aa5-23053bad65a6&Preview=1
Date
12/4/2012
Company Name
Flexion Therapeutics
Mailing Address
300 TradeCenter Woburn, MA 01801
Company Description
Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.
Website
http://www.flexiontherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds will be used to fund late stage clinical development of the company’s portfolio of intra-articular, sustained release therapies for the treatment of osteoarthritis.
M&A Terms
Venture Investor
Novo A/S
Venture Investor
5AM Ventures
Venture Investor
Pfizer Venture Investments
Venture Investor
Sofinnova Ventures
Venture Investor
Versant Ventures
Venture Investor
Versant Ventures